COMMUNIQUÉS West-GlobeNewswire

AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)
05/02/2018
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label [...]
ATW Tech Octroie de Nouvelles Options D’achat D’actions
05/02/2018
MONTREAL, 05 févr. 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX-V: ATW ) annonce qu’aux termes de son régime d’options d’achat d’actions (le « régime »), un total de 2 387 000 options d’ [...]
Appointment of Chairman
05/02/2018
MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr Paul A. Kasian as [...]
Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference
05/02/2018
Press Release 5 February 2018 Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference Immunicum AB (publ; IMMU.ST) a biopharmaceutical company [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/02/2018
REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/02/2018
REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Addex Provides Key Financial Indicators and Trading Update
05/02/2018
Cash position of CHF6.5 million as of 31 January 2018 Geneva, Switzerland, 5 February 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, [...]
Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.
03/02/2018
CONCORD, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]
Emerald Health Files Second Amended and Restated Final Base Shelf Prospectus
02/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. VICTORIA, British Columbia, Feb. [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
02/02/2018
BURLINGTON, Mass., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to six new employees for an aggregate of 38,800 shares of common stock [...]
Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
02/02/2018
BERKELEY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on February 1, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]
Prothena Announces Departure of Chief Medical Officer
02/02/2018
DUBLIN, Ireland, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]
Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 7, 2018
02/02/2018
BOSTON, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
Digirad Announces Closing of Sale of its MDSS Service Contracts to Philips North America
02/02/2018
SUWANEE, Ga., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD ) today announced that it had closed its previously announced definitive purchase agreement with Philips North America (“Philips”) to [...]
Cytokinetics to Announce Fourth Quarter Results on February 15, 2018
02/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that it is scheduled to report fourth quarter results on February 15, 2018 at 4:00 PM Eastern [...]
Tauriga Sciences Inc. Takes Advantage of Market Weakness and Averages Down with Purchase of an Additional $10,000 USD Worth of Crypto Currency Groestlcoin
02/02/2018
NEW YORK, NY, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
Emblem Completes Bought Deal Financing
02/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Company ") is pleased [...]
SENS Research Foundation Receives $2.4 Million Ethereum Donation From Vitalik Buterin
02/02/2018
MOUNTAIN VIEW, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF), a leading Silicon Valley nonprofit focused on diseases of aging, announced today the receipt of a $2.4 million Ethereum donation [...]
SENS Research Foundation Receives an Additional $1 Million Bitcoin Donation From Pineapple Fund
02/02/2018
MOUNTAIN VIEW, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF), a leading nonprofit focused on the development of rejuvenation biotechnologies to address the diseases of aging, announced today [...]

Pages